» Articles » PMID: 12209510

The Determinants of Change in Tibial Cartilage Volume in Osteoarthritic Knees

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 2002 Sep 5
PMID 12209510
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The rate of change in osteoarthritic (OA) tibial articular cartilage and the factors that influence it are not known. We examined a cohort of subjects with OA to determine the change in articular knee cartilage volume over the course of 2 years and to identify factors which might influence such change and its rate.

Methods: One hundred twenty-three subjects with OA underwent baseline knee radiography and magnetic resonance imaging (MRI) on their symptomatic knee. They were followed up 2 years later with a repeat MRI of the same knee. Knee cartilage volume was measured at baseline and at followup. Risk factors assessed at baseline were tested for their association with change in knee cartilage volume over time.

Results: Mean +/- SD total tibial articular cartilage decreased by 5.3 +/- 5.2% (95% confidence interval [95% CI] 4.4%, 6.2%) per year. The annual percentages of loss of medial and lateral tibial cartilage were 4.7 +/- 6.5% (95% CI 3.6%, 5.9%) and 5.3 +/- 7.2% (95% CI 4.1%, 6.6%), respectively. Initial cartilage volume was the most significant determinant of loss of tibial cartilage in all compartments, while age was a significant determinant of lateral tibial cartilage loss, when possible confounders were accounted for.

Conclusion: In OA, tibial cartilage volume is lost at a rate of approximately 5% per year. The main factor affecting cartilage loss is initial cartilage volume. Our results suggest that cartilage loss may be more rapid early in disease. Further study is required to determine whether the rate of cartilage loss in OA is steady or phasic, and to identify factors amenable to intervention to reduce cartilage loss.

Citing Articles

Association between medial meniscal extrusion and knee structural progression in adults with symptomatic knee osteoarthritis - a prospective cohort study.

Zeng M, Cicuttini F, Wluka A, Jones G, Hill C, Ding C Skeletal Radiol. 2024; 54(2):219-228.

PMID: 38879732 PMC: 11652669. DOI: 10.1007/s00256-024-04731-2.


Circulating miR-146b and miR-27b are efficient biomarkers for early diagnosis of Equidae osteoarthritis.

Yassin A, AbuBakr H, Abdelgalil A, Farid O, El-Behairy A, Gouda E Sci Rep. 2023; 13(1):7966.

PMID: 37198318 PMC: 10192321. DOI: 10.1038/s41598-023-35207-3.


Efficacy of intra-articular injection of allogeneic platelet-rich plasma for knee osteoarthritis combined with hematologic blood dyscrasias with platelet dysfunction: protocol of a randomized, double-blind, placebo-controlled trial.

Zhu X, Zhao L, Liu A, Yu Z, Guo J BMC Musculoskelet Disord. 2022; 23(1):1095.

PMID: 36517775 PMC: 9749297. DOI: 10.1186/s12891-022-06073-3.


Association between popliteal artery wall thickness and structural progression in patients with symptomatic knee osteoarthritis.

Wang Y, Pontoh E, Hussain S, Lim Y, Jones G, Hill C Rheumatology (Oxford). 2022; 62(4):1645-1651.

PMID: 35972369 PMC: 10070062. DOI: 10.1093/rheumatology/keac469.


Effect of alendronate sodium plus vitamin D tablets on knee joint structure and osteoarthritis pain: a multi-center, randomized, double-blind, placebo-controlled study protocol.

Peng H, Weng X, Li Y, Feng B, Qian W, Cai D BMC Musculoskelet Disord. 2022; 23(1):584.

PMID: 35715774 PMC: 9205115. DOI: 10.1186/s12891-022-05521-4.